Characterization of Insulin-degrading Enzyme: Using Molecular Visualization Systems to Understand Substrate Recognition in Type 2 Diabetes and Alzheimer’s
ISEF · 2021 Cellular and Molecular Biology
Overview
Amyloid-beta (Aß) and insulin, two substrates of insulin-degrading enzyme (IDE), are critically important in the pathogenesis of Alzheimer's disease (AD) and type 2 diabetes (T2D), respectively. IDE is a major Aß-degrading enzyme, linked with slowed AD progression. Conversely, inhibiting IDE results in retention of insulin, thus reducing T2D symptoms. IDE was identified as a cytosolic enzyme despite substrate degradation occurring in the endosome, raising the question of how the enzyme gains substrate access. Recent studies established the role of phosphatidylinositol phosphates (PtdInsPs) which localize IDE to endosomes through the polyanion-binding site. However, the polyanion-binding site partially overlaps the substrate-binding site, raising concerns that disabling IDE’s localization mechanism could disrupt substrate degradation. The purpose of this project is to produce a mutant version of IDE that does not bind to PtdInsPs to localize to endosomal compartments while retaining full enzyme activity. IDE localization could be disrupted to reduce insulin catabolism without affecting cytosolic IDE, thus slowing the progression of T2D. This innovative project utilized molecular visualization systems and online servers to characterize interactions between IDE and substrate peptides using structures deposited in the Protein Data Bank. Structural analysis revealed that a majority of residues mediating substrate binding are not found in the polyanion binding site. Future studies are aimed at better understanding interactions between PtdInsPs headgroups and IDE to define residues to mutate. These studies provide the molecular basis for substrate recognition and offer insight into designing novel IDE-based therapies to control amyloid-beta and blood sugar concentrations.
Awards (1)
- The Potamkin Prize for Students: First Award
Competition history
- ISEF 2021
Resources
Related projects
ISEF · 2021
De Novo Design of Ubiquitin Substrate for Neuritic Plaque-Busting
ISEF · 2026
Designing Peptide Inhibitors to Prevent Amyloid Beta Aggregation
ISEF · 2025
Discovery and Structure-Based Optimization of Highly Selective PTP1B Inhibitors: A Multi-Stage in silico Workflow Integrating Machine Learning for Ligand-Based Virtual Screening and Molecular Docking & Dynamics Simulations To Enhance Insulin Sensitivity in Type-2 Diabetes
ISEF · 2014
Development of a Therapeutic Drug for Alzheimer’s Disease: A Chemical Approach to Cease Amyloidosis
ISEF · 2018
Attacking Alzheimer's: Developing New Drugs Using Computational Modeling of Beta-Amyloid Protein Binding
ISEF · 2016
Biochemical Characterization and Imaging of Arc: Insights into Neurodegeneration and Alzheimer’s Development
ISEF · 2025
Designing Enhanced DNAJB6 Variants: A New Approach to Prevent Alzheimer's Disease by Inhibiting Amyloid-beta 42 Clumping
ISEF · 2024
Neuropath: Multi-Computational Framework for Developing a Receptor-Based Transcytosis Approach to Facilitate BDNF Transmission for Alzheimer’s Progression Prevention
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair